Sagimet Biosciences (SGMT) Current Assets (2023 - 2024)
Sagimet Biosciences (SGMT) has 2 years of Current Assets data on record, last reported at $157.2 million in Q3 2024.
- For Q3 2024, Current Assets rose 52.88% year-over-year to $157.2 million; the TTM value through Sep 2024 reached $157.2 million, up 52.88%, while the annual FY2023 figure was $96.6 million, N/A changed from the prior year.
- Current Assets reached $157.2 million in Q3 2024 per SGMT's latest filing, down from $166.8 million in the prior quarter.
- Across five years, Current Assets topped out at $194.5 million in Q1 2024 and bottomed at $21.4 million in Q2 2023.